Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Jiefu, Yang"'
Autor:
Dan Liu, Xiaotong Cui, Yamei Xu, Lei Xu, Zhonglei Xie, Shuai Yuan, Peng Wang, Yanyan Wang, Sanli Qian, Hui Gong, Peter Nordbeck, Jiefu Yang, Jingmin Zhou, Junbo Ge, Aijun Sun
Publikováno v:
ESC Heart Failure, Vol 11, Iss 5, Pp 2901-2912 (2024)
Abstract Aims The benefits of lowering heart rate (HR) in heart failure (HF) with preserved ejection fraction (HFpEF) patients are still a matter of debate. This study aimed to investigate the relationship between changes in HR during hospitalization
Externí odkaz:
https://doaj.org/article/20aeb75a10b149788821703c6d4d6073
Publikováno v:
Aging Medicine, Vol 7, Iss 3, Pp 287-291 (2024)
Externí odkaz:
https://doaj.org/article/98739f0d8bf14030b6a7a0fa511b2d82
Publikováno v:
Chinese Medical Journal, Vol 137, Iss 13, Pp 1513-1515 (2024)
Externí odkaz:
https://doaj.org/article/98e8fb8654904706aaa8e292b3902f68
Autor:
Jingmin Zhou, Yamei Xu, Zhaofen Zheng, Shuyang Zhang, Jiefu Yang, Yuhui Zhang, Baopeng Tang, Huiyuan Han, Qing Zhang, Fan Liu, Wenhui Ding, Caizhen Qian, Guohai Su, Xiaohui Liu, Yuansheng Shen, Bei Shi, Xiangqing Kong, Zhiming Ge, Ping Zhang, Xiaomei Guo, Hong Zhang, Yuemin Sun, Yugang Dong, Guosheng Fu, Lei Feng, Junbo Ge, the POSITIVE investigators
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 846-858 (2024)
Abstract Aims A therapeutic strategy for chronic heart failure (HF) is to lower resting heart rate (HR). Ivabradine is a well‐known HR‐lowering agent, but limited prospective data exist regarding its use in Chinese patients. This study aimed to e
Externí odkaz:
https://doaj.org/article/77bb9c7e80e84885bbd09fc252908f36
Autor:
Junpeng Liu, Ke Chai, Wanrong Zhu, Minghui DU, Chen Meng, Lin Yang, Lingling Cui, Di Guo, Ning Sun, Hua Wang, Jiefu Yang
Publikováno v:
BMC Geriatrics, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background the prevalence of physical and multidimensional frailty and their prognostic impact on clinical outcomes in patients with atrial fibrillation (AF) is unclear. Objective to evaluated frailty in a cohort of patients with AF accordin
Externí odkaz:
https://doaj.org/article/96e88cc11e3e4147b4edc87b39391a1f
Publikováno v:
Frontiers in Public Health, Vol 11 (2024)
BackgroundThe body of evidence supporting the beneficial effects of Tai Chi in reducing anxiety and depressive symptoms in older adults is steadily increasing. Nonetheless, there remains a scarcity of studies directly comparing the clinical effective
Externí odkaz:
https://doaj.org/article/ef1958ed5a8740afa489c21ecdd3636d
Autor:
Carolyn S. P. Lam, Ed Harding, Marc Bains, Alex Chin, Naresh Kanumilli, Mark C. Petrie, Paula Pohja-Hutchison, Jiefu Yang, Javed Butler
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Despite advances in the treatment of heart failure (HF) with reduced ejection fraction, people with HF continue to have a high risk of mortality and hospitalisation. Patients also suffer from poor quality of life, with reduced soc
Externí odkaz:
https://doaj.org/article/3aaecdcfdc1041c58349e1c2f1eaa6e9
Autor:
Min Zhang, Hua Wang, Yingying Li, Jiefu Yang, Yujia Liu, Chen Meng, Ke Chai, Yao Luo, Yalin Cheng, Wanrong Zhu
Publikováno v:
BMJ Open, Vol 13, Iss 8 (2023)
Introduction Heart failure (HF) with preserved ejection fraction (HFpEF) has become the main type of HF worldwide. Although large randomised controlled studies have demonstrated the beneficial effects of sodium–glucose cotransporter 2 inhibitors am
Externí odkaz:
https://doaj.org/article/83291b40fefe4976a3a1604ea248942d
Publikováno v:
iScience, Vol 26, Iss 5, Pp 106567- (2023)
Summary: 2D ferromagnets have garnered considerable attention for their potential applications in spintronics, magnonics, and spin-orbitronics. Chromium tellurides (CrxTey), in particular, have drawn interest due to their exceptional magnetic propert
Externí odkaz:
https://doaj.org/article/84cd3e6d16224eae9aca839ccc6db702
Autor:
Qing Zhang, Yuying Qi, Shuanghu Wang, Fangling Zhao, Lili Zou, Quan Zhou, Peiwu Geng, Yun Hong, Hang Yang, Qingfeng Luo, Jianping Cai, Hualan Wu, Dongxu Wang, Hao Chen, Jiefu Yang, Dapeng Dai
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Cytochrome P450 2C9 (CYP2C9) participates in about 15% of clinical drug metabolism, and its polymorphism is associated with individual drug metabolism differences, which may lead to the adverse drug reactions (ADRs). In this study, 1163 Chinese Han i
Externí odkaz:
https://doaj.org/article/2bae00f930ae474fafd9d8c35a4a0063